Biotransplant(BTRN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN)

BTRN 35.48

+0.1%

Dec 8 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (586)	7/11/2000 4:20:00 AM
From: scaram(o)uche	Read Replies (2) of 1475

Don't know anything about Evolution Capital.... has a nice feel to it.......... messages.yahoo.com messages.yahoo.com One "leverage" key, for me, is (and has been for two years) the subcutaneous transition to phase II for psoriasis. Let's hope that (1) it happens, and (2) we get some insights into proposed "mechanism of action". Patent issued that covers all antibodies that react with the 507-determined CD2 epitope.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next